|
[1]
|
Davis, W. and Tew, K.D. (2018) ATP-Binding Cassette Transporter-2 (ABCA2) as a Therapeutic Target. Biochemical Pharmacology, 151, 188-200. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Behl, T., Kaur, I., Sehgal, A., Kumar, A., Uddin, M.S. and Bungau, S. (2021) The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer’s Disease. Molecular Neurobiology, 58, 1564-1582. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Bossaerts, L., Cacace, R. and Van Broeckhoven, C. (2022) The Role of ATP-Binding Cassette Subfamily a in the Etiology of Alzheimer’s Disease. Molecular Neurodegeneration, 17, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Dean, M., Hamon, Y. and Chimini, G. (2001) The Human ATP-Binding Cassette (ABC) Transporter Superfamily. Journal of Lipid Research, 42, 1007-1017. [Google Scholar] [CrossRef]
|
|
[5]
|
Ile, K.E., Davis, W., Boyd, J.T., Soulika, A.M. and Tew, K.D. (2004) Identification of a Novel First Exon of the Human ABCA2 Transporter Gene Encoding a Unique N-terminus. Biochimica et Biophysica Acta (BBA)—Gene Structure and Expression, 1678, 22-32. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Wilkens, S. (2015) Structure and Mechanism of ABC Transporters. F1000Prime Reports, 7, Article 14. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Ambudkar, S.V., Dey, S., Hrycyna, C.A., Ramachandra, M., Pastan, I. and Gottesman, M.M. (1999) Biochemical, Cellular, and Pharmacological Aspects of the Multidrug Transporter. Annual Review of Pharmacology and Toxicology, 39, 361-398. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Mack, J.T., Beljanski, V., Soulika, A.M., Townsend, D.M., Brown, C.B., Davis, W., et al. (2007) “Skittish” abca2 Knockout Mice Display Tremor, Hyperactivity, and Abnormal Myelin Ultrastructure in the Central Nervous System. Molecular and Cellular Biology, 27, 44-53. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Sakai, H., Tanaka, Y., Tanaka, M., Ban, N., Yamada, K., Matsumura, Y., et al. (2007) ABCA2 Deficiency Results in Abnormal Sphingolipid Metabolism in Mouse Brain. Journal of Biological Chemistry, 282, 19692-19699. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Tanaka, Y., Yamada, K., Zhou, C., Ban, N., Shioda, S. and Inagaki, N. (2003) Temporal and Spatial Profiles of ABCA2‐expressing Oligodendrocytes in the Developing Rat Brain. Journal of Comparative Neurology, 455, 353-367. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Zhou, C., Inagaki, N., Pleasure, S.J., Zhao, L., Kikuyama, S. and Shioda, S. (2002) ATP‐Binding Cassette Transporter ABCA2 (ABC2) Expression in the Developing Spinal Cord and PNS during Myelination. Journal of Comparative Neurology, 451, 334-345. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
(2021) 2021 Alzheimer’s Disease Facts and Figures. Alzheimer’s & Dementia, 17, 327-406. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Chen, Z.J., Vulevic, B., Ile, K.E., Soulika, A., Davis, W., Reiner, P.B., et al. (2004) Association of ABCA2 Expression with Determinants of Alzheimer’s Disease. The FASEB Journal, 18, 1129-1131. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Vulevic, B., Chen, Z., Boyd, J.T., Davis Jr., W., Walsh, E.S., Belinsky, M.G. and Tew, K.D. (2001) Cloning and Characterization of Human Adenosine 5’-Triphosphate-Binding Cassette, Sub-Family A, Transporter 2 (ABCA2). Cancer Research, 61, 3339-3347.
|
|
[15]
|
Davis, W. (2010) The ATP-Binding Cassette Transporter-2 (ABCA2) Increases Endogenous Amyloid Precursor Protein Expression and Abeta Fragment Generation. Current Alzheimer Research, 7, 566-577. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Michaki, V., Guix, F.X., Vennekens, K., Munck, S., Dingwall, C., Davis, J.B., et al. (2012) Down-Regulation of the ATP-Binding Cassette Transporter 2 (ABCA2) Reduces Amyloid-Β Production by Altering Nicastrin Maturation and Intracellular Localization. Journal of Biological Chemistry, 287, 1100-1111. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Davis Jr., W. (2015) The ATP-Binding Cassette Transporter-2 (ABCA2) Overexpression Modulates Sphingosine Levels and Transcription of the Amyloid Precursor Protein (APP) Gene. Current Alzheimer Research, 12, 847-859. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Macé, S., Cousin, E., Ricard, S., Génin, E., Spanakis, E., Lafargue-Soubigou, C., et al. (2005) ABCA2 Is a Strong Genetic Risk Factor for Early-Onset Alzheimer’s Disease. Neurobiology of Disease, 18, 119-125. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Wollmer, M.A., Kapaki, E., Hersberger, M., Muntwyler, J., Brunner, F., Tsolaki, M., et al. (2006) Ethnicity‐Dependent Genetic Association of ABCA2 with Sporadic Alzheimer’s Disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141, 534-536. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Xu, X., Wang, Y., Wang, L., Liao, Q., Chang, L., Xu, L., et al. (2013) Meta-Analyses of 8 Polymorphisms Associated with the Risk of the Alzheimer’s Disease. PLoS ONE, 8, e73129. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Inoue, Y., Tsuchida, N., Kim, C.A., de Oliveira Stephan, B., Castro, M.A.A., Honjo, R.S., et al. (2024) Novel Compound Heterozygous ABCA2 Variants Cause IDPOGSA, a Variable Phenotypic Syndrome with Intellectual Disability. Journal of Human Genetics, 69, 163-167. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Aslam, F. and Naz, S. (2019) Ataxia and Dysarthria Due to an ABCA2 Variant: Extension of the Phenotypic Spectrum. Parkinsonism & Related Disorders, 64, 328-331. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Obara, S., Nakata, M., Takeshima, H., Arita, K., Inagaki, N. and Kuratsu, J. (2007) Clinical Significance of ABCA2, a Possible Molecular Marker for Oligodendrogliomas. Neurosurgery, 60, 707-714. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Van den Bent, M.J., Reni, M., Gatta, G. and Vecht, C. (2008) Oligodendroglioma. Critical Reviews in Oncology/Hematology, 66, 262-272. [Google Scholar] [CrossRef] [PubMed]
|